Loading resource…

American Heart Association
Left ventricular (LV) systolic dysfunction is commonly found in patients with ischemic stroke, increasing their risk of incident and recurrent embolic stroke. This document reviews the limited data supporting anticoagulation in these patients and discusses the implications of LV dysfunction on stroke management. It includes a narrative summary and meta-analysis of randomized clinical trials evaluating outcomes of anticoagulation versus nonanticoagulation strategies, highlighting the need for further research on risk stratification and management strategies.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same clinical topic · Cardiology

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same clinical topic · Cardiology

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same clinical topic · Cardiology

2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults
Same clinical topic · Cardiology

2026 ESC GUIDELINES FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE
Same clinical topic · Cardiology

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
Same clinical topic · Cardiology

2026 ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
Same clinical topic · Cardiology

MANAGEMENT OF ACUTE CORONARY SYNDROME
Same clinical topic · Cardiology

Guidelinefor the Prevention, Detection,Evaluation, and Management
Same clinical topic · Cardiology